Etudes scientifiques

BioComptabilité
Audispray solution was tested according to ISO 10993-10 standards by the Biomatech, EVIC-CEBA and CERB laboratories according to Good Laboratory Practice (GLP) :

Investigations showed

1° Good tolerance of the solution by the skin and mucus membranes
2° Total absence of toxicity for local use
3° Absence of allergenic properties
Laboratoires Biomatech have proven the absence of allergens and total absence of toxicity of Audispray.
Etudes invitro
A first study conducted by Professor Dufour of the Faculty of Pharmaceutical Sciences of Bordeaux (France) :

In-Vitro studies carried out by Professor Dufour of the Faculty of Pharmaceutical Sciences of the University of Bordeaux concluded that :  « All the tests carried out demonstrated that Audispray causes a more complete disintegration or lysis of cerumen impactions than the reference preparation used »
Etudes cliniques
Professor Passali , President of the European Federations of ORL Societies and former President of the World Federation of ORL Societies concluded in his study on fifty patients that :

« the “Audispray” solution allowed an important modification of the physical-chemical characteristics of impactions treated by disintegrating the components of cerumen thereby facilitating the cerumen impaction extraction procedures.»
Doctor Salles, neo-natal pediatrician of the Lyon Hospital Center affirmed that :

« the data collected during this study performed on 27 infants (aged 3 to 12 months) showed the good effectiveness (significant decrease of the quantity of cerumen compared to the untreated ear) and also the good tolerance of the Audibaby product »